Condition: Interstitial Lung Disease · Connective Tissue Diseases · Sponsor: University Hospital, Bordeaux
The investigators hypothesize that in patients with a new diagnosis of Pulmonary Interstitial Disease (PID), adding capillaroscopy to standard care increases the proportion of patients receiving a diagnosis of PID-Connective Tissue Disease (PID-CTD) within the first three months of follow-up, thereby reducing the time to diagnosis and facilitating the implementation of appropriate treatment as quickly as possible. Therefore, To confirm this hypothesis, it is necessary to know the characteristics of capillaroscopy in patients with a new diagnosis of PID.
This description comes directly from the study's public registry record.
Marie-Elise TRUCHETET, MD, PhD · 05.56.79.55.56 · marie-elise.truchetet@chu-bordeaux.fr
Thomas BARNETCHE, PhD · thomas.barnetche@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU de Bordeaux - service de rhumatologie | Bordeaux, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07283081